Výsledky vyhľadávania - "Diabetic Nephropathies diagnosis"

  1. 1

    Zdroj: Kidney international, Vol. 106, no.3, p. 369-391 (2024)

    Popis súboru: application/pdf

  2. 2

    Zdroj: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)

    Predmety: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Zdroj: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-8 (2021)

    Predmety: Male, Renal Plasma Flow, Insulin Glargine, Linagliptin, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Type 2 diabetes, Renal, Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Insulin Glargine/adverse effects [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Hemodynamics/drug effects [MeSH], Dipeptidyl-Peptidase IV Inhibitors/therapeutic use [MeSH], Metformin/therapeutic use [MeSH], Original Investigation, Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Metformin/adverse effects [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Drug Therapy, Combination [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Diabetic Nephropathies/prevention, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Diabetic Nephropathies/etiology [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Intraglomerular, Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Linagliptin/adverse effects [MeSH], Prospective Studies [MeSH], Renal Plasma Flow/drug effects [MeSH], Insulin Glargine/therapeutic use [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Hemodynamics, Germany [MeSH], Dipeptidyl-Peptidase IV Inhibitors/adverse effects [MeSH], 03 medical and health sciences, 0302 clinical medicine, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, Hypoglycemic Agents, Diabetic Nephropathies, ddc:610, Prospective Studies, Benzhydryl Compounds, Aged, Dipeptidyl-Peptidase IV Inhibitors, Middle Aged, Metformin, 3. Good health, Diabetes Mellitus, Type 2, RC666-701, Drug Therapy, Combination, Female, Glomerular Filtration Rate

    Popis súboru: application/pdf

  8. 8
  9. 9

    Zdroj: Kidney International. 93:1198-1206

  10. 10
  11. 11

    Zdroj: Front Endocrinol (Lausanne)
    Frontiers in Endocrinology, Vol 12 (2021)
    Frontiers in endocrinology, 12:670674

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20